• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Mirus Bio Releases for Sale TransIT(R)-2020; a New Broad Spectrum, Animal-Free Transfection Reagent to Go Head to Head With FuGENE(R) HD and Lipofectamine(TM) 2000

Posted on: Tuesday, 8 September 2009, 16:27 CDT

MADISON, Wis., Sept. 8 /PRNewswire/ -- From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:

• Superior Performance--TransIT(R)-2020 outperforms FuGENE(R) HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types.
• Broad Spectrum DNA Delivery--Achieve high transgene expression in many cell types, including hard to transfect cells.
• Animal Origin free-- TransIT(R)-2020 provides high performance with maximum compatibility.
• Scientifically Proven--Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.
  

Visit www.mirusbio.com for all your transfection needs including data, protocols, technical support or to place an order.

The Transfection Experts

For over a decade, Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.

SOURCE Mirus Bio LLC

Source: PR Newswire

More News in this Category